Mission
Delta International Services &
Logistics is an agency created for the international development
of
Scrambler Therapy® Technology , a medical device for
the treatment of chronic neuropathic and oncologic pain resistant
to opiates and other types of treatment, including implanted
devices.
The scientific literature indexed and
published in peer review scientific journals, based exclusively on
this technology, shows several clinical studies on:
- Symptomatic relief of chronic
opioid-resistant pain.
- Symptomatic relief of chronic
neuropathic and oncological pain.
In general, this device in the
clinical studies is indicated for forms of severe chronic pain, in
particular that which does not respond to other pharmacological
and non-pharmacological treatments, including opioids.
The Scrambler Therapy® device has
been used to successfully treat thousands of patients worldwide,
where it has been shown to be effective in treating neuropathic
and oncologic pain. Scrambler Therapy® is a stand-alone medical
electroanalgesia device, and does not require combinations with
other analgesic therapies.
International
distribution
DIS&L through its law
firm is the only company authorized to sign international
exclusive agreements in all international area , provide
maintenance and distributor support for method usage training
and other logistics needs. To request a national exclusive
agreement the candidate distributor must have minimum
requirements listed on the “
Distributor Requirement ” page.
